Group One Trading’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-105
| Closed | -$2.1K | – | 8171 |
|
|
2022
Q4 | $2.1K | Hold |
105
| – | – | ﹤0.01% | 6641 |
|
|
2022
Q3 | $2K | Buy |
+105
| New | +$2.25K | ﹤0.01% | 7233 |
|
|
2022
Q2 | – | Sell |
-700
| Closed | -$19K | – | 8753 |
|
|
2022
Q1 | $19K | Sell |
700
-1,940
| -73% | -$70.6K | ﹤0.01% | 6796 |
|
|
2021
Q4 | $120K | Sell |
2,640
-2,440
| -48% | -$164K | ﹤0.01% | 5565 |
|
|
2021
Q3 | $424K | Buy |
5,080
+4,010
| +375% | +$332K | ﹤0.01% | 4384 |
|
|
2021
Q2 | $102K | Buy |
1,070
+535
| +100% | +$63.5K | ﹤0.01% | 5934 |
|
|
2021
Q1 | $89K | Buy |
535
+480
| +873% | +$63.5K | ﹤0.01% | 5764 |
|
|
2020
Q4 | $5K | Buy |
+55
| New | +$3.48K | ﹤0.01% | 6051 |
|
|
2019
Q4 | – | Sell |
-50
| Closed | -$5K | – | 5764 |
|
|
2019
Q3 | $5K | Sell |
50
-915
| -95% | -$93.7K | ﹤0.01% | 4786 |
|
|
2019
Q2 | $129K | Buy |
965
+594
| +160% | +$91.7K | ﹤0.01% | 3164 |
|
|
2019
Q1 | $62K | Sell |
371
-13
| -3% | -$1.94K | ﹤0.01% | 3462 |
|
|
2018
Q4 | $42K | Buy |
384
+154
| +67% | +$30.8K | ﹤0.01% | 3651 |
|
|
2018
Q3 | $51K | Buy |
+230
| New | +$552K | ﹤0.01% | 3960 |
|
|
2017
Q1 | – | Sell |
-9
| Closed | -$6K | – | 5109 |
|
|
2016
Q4 | $6K | Buy |
9
+4
| +80% | +$4.28K | ﹤0.01% | 4079 |
|
|
2016
Q3 | $5K | Sell |
5
-1
| -17% | -$872 | ﹤0.01% | 4228 |
|
|
2016
Q2 | $5K | Buy |
6
+5
| +500% | +$4.67K | ﹤0.01% | 4290 |
|
|
2016
Q1 | $1K | Sell |
1
-1
| -50% | -$867 | ﹤0.01% | 4462 |
|
|
2015
Q4 | $2K | Sell |
2
-2
| -50% | -$2.64K | ﹤0.01% | 4550 |
|
|
2015
Q3 | $5K | Sell |
4
-1
| -20% | -$1.46K | ﹤0.01% | 4512 |
|
|
2015
Q2 | $10K | Buy |
5
+4
| +400% | +$5.68K | ﹤0.01% | 4297 |
|
|
2015
Q1 | $1K | Sell |
1
-6
| -86% | -$5.96K | ﹤0.01% | 4656 |
|
|
2014
Q4 | $7K | Sell |
7
-5
| -42% | -$4.46K | ﹤0.01% | 4368 |
|
|
2014
Q3 | $12K | Sell |
12
-1
| -8% | -$1.47K | ﹤0.01% | 4390 |
|
|
2014
Q2 | $25K | Sell |
13
-15
| -54% | -$29.7K | ﹤0.01% | 4020 |
|
|
2014
Q1 | $59K | Sell |
28
-18
| -39% | -$44.8K | ﹤0.01% | 3507 |
|
|
2013
Q4 | $106K | Sell |
46
-65
| -59% | -$149K | ﹤0.01% | 2978 |
|
|
2013
Q3 | $313K | Buy |
111
+44
| +66% | +$219K | 0.01% | 2004 |
|
|
2013
Q2 | $621K | Buy |
+67
| New | +$516K | 0.02% | 1169 |
|
Other funds holding ONCT
BC
KCM
QPW
BJL
Group One Trading's ONCT Position: Q3 2022 in Review
Group One Trading sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q3 2022, closing a stake of 1,040 shares — an estimated $22.3K sold.
Group One Trading first reported a position in ONCT in Q1 2014 and held it in 20 quarters. The position peaked at $214K in Q1 2021. 61 funds tracked by Wall St. Rank hold ONCT as of Q3 2022.
- Group One Trading reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Group One Trading sold 1,040 Oncternal Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $22.3K.
- Group One Trading first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q1 2014 and held it in 20 quarters.
- Group One Trading's Oncternal Therapeutics, Inc. Common Stock position peaked at $214K in Q1 2021.
- 61 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2022.
Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.